1. Home
  2. OC vs SYRE Comparison

OC vs SYRE Comparison

Compare OC & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owens Corning Inc New

OC

Owens Corning Inc New

HOLD

Current Price

$114.33

Market Cap

9.5B

Sector

Industrials

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$90.45

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OC
SYRE
Founded
1938
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.7B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
OC
SYRE
Price
$114.33
$90.45
Analyst Decision
Buy
Strong Buy
Analyst Count
18
18
Target Price
★ $148.50
$119.93
AVG Volume (30 Days)
951.5K
★ 1.4M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 2.71%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.50
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.72
N/A
P/E Ratio
$77.92
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$97.53
$21.15
52 Week High
$159.91
$110.18

Technical Indicators

Market Signals
Indicator
OC
SYRE
Relative Strength Index (RSI) 43.13 54.50
Support Level $106.24 $81.36
Resistance Level $129.58 $94.10
Average True Range (ATR) 3.87 4.93
MACD 0.86 1.40
Stochastic Oscillator 49.10 75.04

Price Performance

Historical Comparison
OC
SYRE

About OC Owens Corning Inc New

Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: